Perioperative complications and surgical oncology outcomes in an initial study from 84 patients submitted to laparoscopic radical cystectomy.
OBJECTIVE
The Gold Standard treatment for a non-metastatic, invasive bladder cancer is an open radical cystoprostatectomy (ORCP). Laparoscopic radical cystoprostatectomy (LRCP) is still an experimental technique in evaluation. We describe our perioperative results defined as surgical and safety oncology variables.


METHODS
Every patient who underwent a LRCP between January 2007 and July 2011 in the urology department of the University Public Hospital was evaluated. We perform a descriptive retrospective analysis.


RESULTS
We evaluated 84 patients, 72 males and 12 females, with a mean age of 68 (44-79). A Bricker diversion was performed in 80 patients, a Camey II bladder replacement was performed in 3 patients, and a Studer bladder replacement was performed in 1 patient. Seventeen patients (20.23%) presented with previous abdominal surgery, and 6 patients (7.14%) presented a medical history of urological surgery. The mean surgery time was 257.57 minutes (180-420). The mean hospital stay was 11.875 days (standard deviation (SD): 6.28). The onset of tolerance to surgery occurred after 3.7 days (SD: 2.21).The transfusion rate after surgical intervention was 20.2%. The mean number of nodes removed, by means of ilio-obturator lymphadenectomy, was 17 (13-19). There were no intraoperative complications. Early complications (less than 1 month after the intervention) occurred in 28 patients (33.3% ).There were no post-operative deaths. There were late complications (starting one month after the intervention) in 7 patients (8.3% ).


CONCLUSIONS
Our study demonstrated that LRCP is safe and reproducible and represents a minimally invasive option for patients with infiltrative bladder cancer.
Urology Service.Hospital Universitario de Leon. Leon.Spain.
Lorena
L
Ortiz-Sanchez
Francisco
F
Campanario-Perez
Fructuoso
F
Garcia-Diez
Manuel Emilio
ME
Beneitez-Alvarez
Miguel Angel
MA
Alonso-Prieto
Rafael
R
Guerreiro-Gonzalez
Miguel Angel
MA
Rado-Velazquez
Juan Manuel
JM
Roa-Luzuriaga
Angello Maria
AM
Viggiano-Romano
Mario
M
De Arriba-Alonso
Alejandro
A
Sanz-Ruiz
Javier
J
Flores-Carvajal
Francisco Javier
FJ
Gallo Rolania
D000328:Adult; D000368:Aged; D019072:Antibiotic Prophylaxis; D015653:Cystectomy / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D007422:Intestines / Q000637:transplantation; D007431:Intraoperative Complications / Q000453:epidemiology* / Q000628:therapy; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods*; D008136:Longevity; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D011183:Postoperative Complications / Q000453:epidemiology* / Q000628:therapy; D018570:Risk Assessment; D016896:Treatment Outcome; D014513:Ureter / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000601:surgery*